Matches in Wikidata for { <http://www.wikidata.org/entity/Q64109947> ?p ?o ?g. }
- Q64109947 description "article scientifique publié en 2015" @default.
- Q64109947 description "artículu científicu espublizáu en setiembre de 2015" @default.
- Q64109947 description "scientific article published on 19 September 2015" @default.
- Q64109947 description "wetenschappelijk artikel" @default.
- Q64109947 description "наукова стаття, опублікована в липні 2016" @default.
- Q64109947 name "Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing r" @default.
- Q64109947 name "Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing r" @default.
- Q64109947 type Item @default.
- Q64109947 label "Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing r" @default.
- Q64109947 label "Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing r" @default.
- Q64109947 prefLabel "Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing r" @default.
- Q64109947 prefLabel "Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing r" @default.
- Q64109947 P1433 Q64109947-F9E50EF2-9F40-4A06-A761-D277054370B4 @default.
- Q64109947 P1476 Q64109947-C49275EF-B43A-465B-94F8-6AD222459477 @default.
- Q64109947 P2093 Q64109947-199AC7C5-C00A-4A68-B4D5-408BA96A8B1E @default.
- Q64109947 P2093 Q64109947-3F54BA94-4E9C-4063-A3F1-370CED7B8BF2 @default.
- Q64109947 P2093 Q64109947-4B621763-BD44-4C74-A53B-82E63BF48565 @default.
- Q64109947 P2093 Q64109947-4FE5C2D1-C147-420A-802E-3B1705721B19 @default.
- Q64109947 P2093 Q64109947-54C73CA6-CF7C-4423-B9A0-55D3FC9DE970 @default.
- Q64109947 P2093 Q64109947-60EF7F8A-881E-4127-909A-DAB60D266ADF @default.
- Q64109947 P2093 Q64109947-667B4787-0C8A-413F-B412-5AA9EB5C5C91 @default.
- Q64109947 P2093 Q64109947-6B12F0AB-EDAC-42FB-BC29-77784DABC9F6 @default.
- Q64109947 P2093 Q64109947-9C77819F-D744-4191-9D14-7C337F4A3460 @default.
- Q64109947 P2093 Q64109947-A8EA215B-3D30-4EFA-A605-DBAAE5B86C35 @default.
- Q64109947 P2093 Q64109947-F05FB724-6B8E-41E7-BE83-86A398AC8461 @default.
- Q64109947 P2093 Q64109947-F20F7F5B-DE8F-498A-A2B7-FF0D4AD3EAEB @default.
- Q64109947 P2860 Q64109947-04B22D50-E2DA-42C8-BDEC-0FDCAF1028D3 @default.
- Q64109947 P2860 Q64109947-0A018AC4-A931-4AAA-A629-A03E5B826C6C @default.
- Q64109947 P2860 Q64109947-11BF98E3-BC6D-475C-8684-301D05C70997 @default.
- Q64109947 P2860 Q64109947-264C6018-8603-4A9A-B908-CFE5CD570D98 @default.
- Q64109947 P2860 Q64109947-281A7C3A-7CB3-435C-8799-FEDF22E48A46 @default.
- Q64109947 P2860 Q64109947-32657E1E-671B-4C52-B216-192344D1687B @default.
- Q64109947 P2860 Q64109947-355FD806-D741-4385-AFB3-CA5C011822ED @default.
- Q64109947 P2860 Q64109947-3DD38755-EE7A-4B9F-9556-3CD9BCE34473 @default.
- Q64109947 P2860 Q64109947-55C02F97-9624-4FFE-9D4C-0971E6CAA2DE @default.
- Q64109947 P2860 Q64109947-5B1823FB-5D17-4D3A-B1E8-A56989AC0837 @default.
- Q64109947 P2860 Q64109947-7A0E2DEA-AF9E-49BE-8E42-2C9F7949C427 @default.
- Q64109947 P2860 Q64109947-824C292D-5956-4FDC-A3DE-38981816764D @default.
- Q64109947 P2860 Q64109947-8BD2BC25-4D3B-4DB8-835F-160D4A32BD46 @default.
- Q64109947 P2860 Q64109947-9AA89B1C-5AAA-497F-A23F-129F30E29787 @default.
- Q64109947 P2860 Q64109947-9B3A3E95-6B53-426E-AE71-63865878F14C @default.
- Q64109947 P2860 Q64109947-A108F926-E7BD-4328-A272-4092417652C5 @default.
- Q64109947 P2860 Q64109947-A7F4B466-AFDE-403E-9266-8A12B851D1E7 @default.
- Q64109947 P2860 Q64109947-C1BD8C2D-9C1D-4689-BA93-890530A1FF92 @default.
- Q64109947 P2860 Q64109947-D203AB6A-D561-40B8-BDFB-16F62ED12FD0 @default.
- Q64109947 P2860 Q64109947-D29D9676-6864-4C98-B042-A4BDF1BF2CE2 @default.
- Q64109947 P2860 Q64109947-DE4275E7-C531-4BE3-9CAC-5169E23220C9 @default.
- Q64109947 P2860 Q64109947-DF4AAE3E-2D77-4198-A75B-1FA8559F0297 @default.
- Q64109947 P2860 Q64109947-E49348DD-C44D-432A-A504-5C00BFAA70B1 @default.
- Q64109947 P2860 Q64109947-F73832C4-51D4-44CD-9903-F48A1A4DFEAF @default.
- Q64109947 P2860 Q64109947-FE708E94-C630-418E-917D-133F55B548F9 @default.
- Q64109947 P2860 Q64109947-FFC4FF54-79BD-431D-AEAB-A4326F536E35 @default.
- Q64109947 P2888 Q64109947-D2C290CD-8B45-4806-94DB-C441FCE89499 @default.
- Q64109947 P304 Q64109947-083B6653-0C9E-4332-8345-FC4167725971 @default.
- Q64109947 P31 Q64109947-912A1CE4-7C9D-4BE6-B5C0-72882CAC946A @default.
- Q64109947 P356 Q64109947-3FBBCE7F-BD64-4EE6-9A55-40899DEF7EBC @default.
- Q64109947 P407 Q64109947-DBE17901-5720-48B7-8963-BCA5B31BB0C6 @default.
- Q64109947 P433 Q64109947-5B8D121D-4508-4640-8730-7CE3B0AC74A7 @default.
- Q64109947 P478 Q64109947-9B86CDB3-F206-4173-B77B-EBA29050D324 @default.
- Q64109947 P50 Q64109947-3AE6D7B6-DA1F-44AF-9E57-201222850133 @default.
- Q64109947 P50 Q64109947-3DC3BCB3-A496-44E6-AADC-82E6A2154E91 @default.
- Q64109947 P50 Q64109947-583FA1CB-DF97-436F-819A-690DEFA8F882 @default.
- Q64109947 P577 Q64109947-0DAD25DF-3E05-4F6A-A282-31C12F94578C @default.
- Q64109947 P6179 Q64109947-C2D2B8B2-07D3-4B43-965F-FE8996F40599 @default.
- Q64109947 P698 Q64109947-9265848E-8F22-4700-92D6-8CDAB69B079E @default.
- Q64109947 P921 Q64109947-20E82E52-4F7F-4AF0-977A-491917C8175C @default.
- Q64109947 P921 Q64109947-4C2F9A04-EE4D-4A28-8FF6-0F17A666C328 @default.
- Q64109947 P921 Q64109947-B626A259-56EB-4BB1-B3AB-6225DA99482E @default.
- Q64109947 P921 Q64109947-D4F612D8-A1F8-4F7F-928B-014FAA537515 @default.
- Q64109947 P356 S10120-015-0542-8 @default.
- Q64109947 P698 26386560 @default.
- Q64109947 P1433 Q15724608 @default.
- Q64109947 P1476 "Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)" @default.
- Q64109947 P2093 "Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group" @default.
- Q64109947 P2093 "Hirofumi Yasui" @default.
- Q64109947 P2093 "Hiroki Kawai" @default.
- Q64109947 P2093 "Junki Mizusawa" @default.
- Q64109947 P2093 "Kenichi Nakamura" @default.
- Q64109947 P2093 "Kenji Amagai" @default.
- Q64109947 P2093 "Kensei Yamaguchi" @default.
- Q64109947 P2093 "Masahiro Gotoh" @default.
- Q64109947 P2093 "Norisuke Nakayama" @default.
- Q64109947 P2093 "Tomohiro Nishina" @default.
- Q64109947 P2093 "Yasuhiro Shimada" @default.
- Q64109947 P2093 "Yasuo Hamamoto" @default.
- Q64109947 P2860 Q29620687 @default.
- Q64109947 P2860 Q31044850 @default.
- Q64109947 P2860 Q33313072 @default.
- Q64109947 P2860 Q33387696 @default.
- Q64109947 P2860 Q33488159 @default.
- Q64109947 P2860 Q34588472 @default.
- Q64109947 P2860 Q34603290 @default.
- Q64109947 P2860 Q34616772 @default.
- Q64109947 P2860 Q42608504 @default.
- Q64109947 P2860 Q44118866 @default.
- Q64109947 P2860 Q44293408 @default.
- Q64109947 P2860 Q44754243 @default.
- Q64109947 P2860 Q45034321 @default.
- Q64109947 P2860 Q46287658 @default.
- Q64109947 P2860 Q46350650 @default.